Table 2.
Definition of key terms used in the assessments.
Term | Definition and reference |
Cancer research | As defined in the NIH statute [1] |
Minority groups | As defined in the NIH statute [1] |
Race and ethnicity | As defined in the Office of Minority Health (OMH) 2016 Industry Guidance Document Collection of Race and Ethnicity Data in Clinical Trials [2] |
Cancer health disparity | The National Cancer Institute defines a cancer health disparity as an adverse difference in cancer incidence (new cases), cancer prevalence (all existing cases), cancer death (mortality), cancer survivorship, and burden of cancer or related health conditions that exist among specific population groups in the US [3] |
Accrual | Accrual is based on the number of participants that have completed or are actively in the process of completing the study. This includes dropouts but does not include screen failures [4] |
[1] Available at: https://grants.nih.gov/grants/funding/women_min/guidelines.htm (accessed May 01, 2019); [2] Available at: https://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM126396.pdf (accessed May 01, 2019); [3] Available at: https://www.cancer.gov/about-nci/organization/crchd/about-health-disparities/definitions (accessed May 01, 2019); [4] Corregano L et al. Clin Transl Sci. 2015; 8(6): 655–661.